Cannabis Science Inc (CBIS) 0.0360 $CBIS
DigiPath Pushes for Uniform Standards in Cannabis Testing
ACCESSWIRE - Thu Sep 10, 11:53PM CDT
SEATTLE, WA / ACCESSWIRE / September 11, 2015 / The cannabis industry could reach $35 billion in size by 2020, if all 50 states legalized marijuana and the federal government ended prohibition, according to GreenWave Advisors. Despite the industry's explosive growth, state governments have been slow to implement consistent regulations when it comes to cannabis safety standards, while the federal government has remained all but absent from any cannabis-related discussions.
MRK: 52.09 (-0.63)
Attention: Due Diligence offers Guidance for Shareholders
ACCESSWIRE - Wed Sep 09, 7:45AM CDT
NEW YORK, NY / ACCESSWIRE / September 9, 2015 / Broad Street Alerts reviewed the medical and recreational-use marijuana industry in the United States, specifically highlighting four companies. These companies include AeroGrow International, Inc. (OTCQB: AERO), GW Pharmaceuticals plc (NASDAQ: GWPH), Medbox, Inc. (OTCQB: MDBX), and Cannabis Science, Inc. (OTCBB: CBIS).
GWPH: 105.64 (+0.79)
Cannabis Science Files Preliminary Schedule 14C Filing to Officially Issue Dividend Payouts for Previous and Current Shareholders
Marketwired - Thu Sep 03, 8:02AM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce it has filed its preliminary Schedule 14C filing as the next steps to complete its dividend payout of the previously filed dividend share payout as filed with the S.E.C. on a Definitive Schedule 14C on August 18, 2011 and include all shareholders in on what the Company considers a landmark growth curve.
Cashing in on Cannabis: CrowdGather's Smart Approach to Capturing Value From the Industry
ACCESSWIRE - Mon Aug 24, 7:00AM CDT
REDONDO BEACH, CA / ACCESSWIRE / August 24, 2015 / The cannabis industry could reach $35 billion in size by 2020, according to GreenWave Advisors, while it's generally considered to be the fastest growing industry in the U.S. economy. While these dynamics should make the industry ripe for investment, the murky legality of industry on a federal level and the opaque nature of many existing publicly-traded companies in the space (that went public through reverse mergers) have made it treacherous for investors.
GWPH: 105.64 (+0.79)
Cannabis Science to Issue Dividend Payouts for Previous and Current Shareholders, a $15-25 Million Capital Raise for FDA and Other Clinical Drug Development Programs as Well as a Proposed NASDAQ Up Listing
Marketwired - Tue Aug 18, 8:36AM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce the closure and issuance of the previously filed dividend share payout as filed with the S.E.C. on a Definitive Schedule 14C on August 18, 2011, the Definitive Schedule 14C filing (RULE 14c-101). The Company also intends to file another Information Statement to accommodate new shareholders to date to receive a similar dividend payout, to bring all shareholders in on what the Company considers a landmark growth curve. The Company expects to accelerate its current FDA targeted drug development programs and expand its State-by-State initiatives. Increasing shareholder value is of foremost importance for everyone involved; to this end the Company will apply for a unique trading symbol to accommodate a $15 - 25 million USD range financing it has been actively negotiating for the newly created class of dividend payout Common A stock, and formally pursue a contemplated up listing to NASDAQ. The Company expects to begin filing the complete new structure program with no reverse split by the end of the month.
DigiPath Pushes for Uniform Standards in Cannabis Testing
ACCESSWIRE - Thu Sep 10, 11:53PM CDT
SEATTLE, WA / ACCESSWIRE / September 11, 2015 / The cannabis industry could reach $35 billion in size by 2020, if all 50 states legalized marijuana and the federal government ended prohibition, according to GreenWave Advisors. Despite the industry's explosive growth, state governments have been slow to implement consistent regulations when it comes to cannabis safety standards, while the federal government has remained all but absent from any cannabis-related discussions.
MRK: 52.09 (-0.63)
Attention: Due Diligence offers Guidance for Shareholders
ACCESSWIRE - Wed Sep 09, 7:45AM CDT
NEW YORK, NY / ACCESSWIRE / September 9, 2015 / Broad Street Alerts reviewed the medical and recreational-use marijuana industry in the United States, specifically highlighting four companies. These companies include AeroGrow International, Inc. (OTCQB: AERO), GW Pharmaceuticals plc (NASDAQ: GWPH), Medbox, Inc. (OTCQB: MDBX), and Cannabis Science, Inc. (OTCBB: CBIS).
GWPH: 105.64 (+0.79)
Cannabis Science Files Preliminary Schedule 14C Filing to Officially Issue Dividend Payouts for Previous and Current Shareholders
Marketwired - Thu Sep 03, 8:02AM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce it has filed its preliminary Schedule 14C filing as the next steps to complete its dividend payout of the previously filed dividend share payout as filed with the S.E.C. on a Definitive Schedule 14C on August 18, 2011 and include all shareholders in on what the Company considers a landmark growth curve.
Cashing in on Cannabis: CrowdGather's Smart Approach to Capturing Value From the Industry
ACCESSWIRE - Mon Aug 24, 7:00AM CDT
REDONDO BEACH, CA / ACCESSWIRE / August 24, 2015 / The cannabis industry could reach $35 billion in size by 2020, according to GreenWave Advisors, while it's generally considered to be the fastest growing industry in the U.S. economy. While these dynamics should make the industry ripe for investment, the murky legality of industry on a federal level and the opaque nature of many existing publicly-traded companies in the space (that went public through reverse mergers) have made it treacherous for investors.
GWPH: 105.64 (+0.79)
Cannabis Science to Issue Dividend Payouts for Previous and Current Shareholders, a $15-25 Million Capital Raise for FDA and Other Clinical Drug Development Programs as Well as a Proposed NASDAQ Up Listing
Marketwired - Tue Aug 18, 8:36AM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce the closure and issuance of the previously filed dividend share payout as filed with the S.E.C. on a Definitive Schedule 14C on August 18, 2011, the Definitive Schedule 14C filing (RULE 14c-101). The Company also intends to file another Information Statement to accommodate new shareholders to date to receive a similar dividend payout, to bring all shareholders in on what the Company considers a landmark growth curve. The Company expects to accelerate its current FDA targeted drug development programs and expand its State-by-State initiatives. Increasing shareholder value is of foremost importance for everyone involved; to this end the Company will apply for a unique trading symbol to accommodate a $15 - 25 million USD range financing it has been actively negotiating for the newly created class of dividend payout Common A stock, and formally pursue a contemplated up listing to NASDAQ. The Company expects to begin filing the complete new structure program with no reverse split by the end of the month.
